Today: 10 Fevereiro 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 129

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. shelves and stokes obesity-drug pricing fears

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. shelves and stokes obesity-drug pricing fears

Eli Lilly shares dropped 3.4% to $1,043.14 after Novo Nordisk launched U.S. sales of an oral Wegovy weight-loss pill starting at $149 a month. Novo’s move intensified focus on pricing in the obesity drug market. The Health Care Select Sector SPDR ETF fell 1.3%, while Novo Nordisk shares rose 2.9%. Investors are awaiting Lilly’s next earnings update on February 4.
5 Janeiro 2026
···
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics shares fell 9.9% to $31.93 Monday after Novo Nordisk launched its Wegovy weight-loss pill in the U.S. with starter doses priced at $149 per month for cash-pay patients. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly dropped 3.9%. Viking’s next updates include Phase 3 trial milestones in Q1 and an earnings release expected Feb. 4.
5 Janeiro 2026
·····
Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. market and revives price pressure fears

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. market and revives price pressure fears

Eli Lilly shares fell 3.6% to $1,041.51 in after-hours trading Monday after Novo Nordisk launched a pill version of its Wegovy weight-loss drug in the U.S. Novo’s shares rose 5.2% as investors reacted to new pricing and distribution details. Lilly’s stock traded as low as $1,034 earlier in the session. Investors await commentary at the J.P. Morgan Healthcare Conference and Lilly’s earnings call.
6 Janeiro 2026
···
Qualcomm stock rises as CES 2026 brings Google auto tie-up, Snapdragon X2 Plus AI PC push

Qualcomm stock rises as CES 2026 brings Google auto tie-up, Snapdragon X2 Plus AI PC push

Qualcomm shares climbed 3.4% to $182.25 after announcing new products and an expanded automotive partnership with Google at CES 2026. The company launched its Snapdragon X2 Plus PC platform and detailed new tools for software-defined vehicles. The stock traded between $176.50 and $184.38 during the session. Investors await further design-win updates and the next quarterly report.
6 Janeiro 2026
···
Spotify (SPOT) stock slides 3% in regular trade as investors eye jobs data and Feb. 10 earnings

Spotify (SPOT) stock slides 3% in regular trade as investors eye jobs data and Feb. 10 earnings

Spotify shares fell 3.3% to $574.00 by midafternoon Tuesday, underperforming the broader market. Trading volume was below average ahead of Friday’s U.S. jobs data. The drop reversed Monday’s gains and put the stock back below $600. Spotify launched a podcast campaign tied to the Golden Globes and introduced a Governors Ball feature in its app.
6 Janeiro 2026
··
Meta stock ticks up after-hours as Ray-Ban Display rollout is paused on U.S. demand

Meta stock ticks up after-hours as Ray-Ban Display rollout is paused on U.S. demand

Meta Platforms shares rose 0.3% to $660.62 in after-hours trading after the company paused international expansion of its Ray-Ban Display smart glasses, citing high U.S. demand and limited supply. Waitlists now extend into 2026, delaying launches in the UK, France, Italy, and Canada. Meta named C.J. Mahoney as chief legal officer, replacing Jennifer Newstead. First-quarter unit sales for the glasses reached about 15,000, or 6% market share.
6 Janeiro 2026
··
Meta Platforms stock drops as China reviews Manus AI deal, legal risks resurface

Meta Platforms stock drops as China reviews Manus AI deal, legal risks resurface

Meta shares fell 2.2% to $646.20 Wednesday after reports that Chinese officials are reviewing its $2 billion acquisition of AI startup Manus, raising the risk of regulatory delays. A U.S. appeals court also appeared skeptical of Meta’s bid to dismiss lawsuits over alleged harm to children. C.J. Mahoney was named chief legal officer, succeeding Jennifer Newstead, who will join Apple in March.
7 Janeiro 2026
·
Strategy stock jumps on MSCI reprieve for bitcoin-treasury firms — but a key limit stays

Strategy stock jumps on MSCI reprieve for bitcoin-treasury firms — but a key limit stays

MSCI said it will not exclude digital asset treasury companies from its indexes in February 2026, pausing planned changes and opening a broader consultation. Shares of Strategy rose as much as 6% after hours and were last up 3.2% Wednesday morning, before trimming gains as bitcoin fell. MSCI will freeze certain index-weight inputs and halt new additions or size changes for affected stocks.
7 Janeiro 2026
·
Meta stock drops after hours as court fight and smart-glasses supply squeeze keep traders cautious

Meta stock drops after hours as court fight and smart-glasses supply squeeze keep traders cautious

Meta Platforms shares dropped 1.8% to $648.69 in after-hours trading Wednesday amid investor rotation in big tech. The company paused international expansion of its Ray-Ban Display smart glasses due to U.S. demand and supply limits. Mark Zuckerberg named C.J. Mahoney as chief legal officer, replacing Jennifer Newstead, who will join Apple. U.S. job openings fell in November, while private payroll growth lagged forecasts.
7 Janeiro 2026
·
AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie shares fell 4% to $224.13 in after-hours trading Thursday after the company cut its 2025 adjusted profit forecast and disclosed a $1.3 billion acquired R&D charge. The company lowered its full-year 2025 adjusted EPS outlook to $9.90–$9.94 from $10.61–$10.65. AbbVie denied takeover talks with Revolution Medicines. Investors await the company’s Feb. 4 earnings report for further guidance.
9 Janeiro 2026
···
P&G stock rises after Crest toothpaste label deal in Texas puts PG back in focus

P&G stock rises after Crest toothpaste label deal in Texas puts PG back in focus

Procter & Gamble shares rose 2.5% to $141.53 after agreeing with Texas officials to change Crest children’s toothpaste packaging to clarify dosing. The rollout began Jan. 1, with P&G required to comply for five years. Piper Sandler started coverage at Neutral with a $150 target; TD Cowen cut its target to $150. Investors await Friday’s U.S. jobs report and P&G’s earnings on Jan. 22.
9 Janeiro 2026
·
Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray shares jumped nearly 9% to $9.95 in premarket trading after reporting fiscal Q2 revenue of $217.5 million and a narrowed net loss of $43.5 million. The company reaffirmed its full-year adjusted profit target and said it moved to a net cash position. Gross margin slipped, and craft beer sales remained under pressure. Traders are watching if the gains hold at the open.
9 Janeiro 2026
··
Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies India’s IPO share allotment is set for Jan. 9 after the offer drew 768 times subscription, with retail and non-institutional investors leading demand, BSE data showed. Shares are scheduled to list Jan. 13 on the BSE SME platform. Grey market prices hovered near 113 rupees, about 40% above the issue price, though this market is unregulated. The IPO was a fresh issue of 3.6 million shares at 76–81 rupees each.
9 Janeiro 2026
··
1 … 127 128 129 130 131 … 172
Go toTop